SYnAbs monoclonal antibodies

Wednesday, 21 October, 2020 | Supplied by: Sapphire Bioscience

SYnAbs produces innovative monoclonal antibodies against poor immunogenic compounds and complex antigens. Targeting steroids, peptides, small molecules, toxins, lipids and polysaccharides (on fungi and bacteria), the company has developed strong expertise in immunology to break immunotolerance in rat and guinea pig species, generating monoclonal antibodies of high specificity and affinity. The antibodies are useful in the fields of hormones, toxins, autoimmune diseases and oncology.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022

Antibodies Inc Recombinant Antibodies

Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.

Bioss Multiplex Fluorescent IHC Staining Kit

The Bioss Multiplex Fluorescent (5 Colors) IHC Staining Kit enables the simultaneous detection of...

AdipoGen Immune Checkpoint Reagents for Immuno-Oncology Research

AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...

Content from other channels on our network

From smart sensors to autonomous factories: why the next decade of AI will transform industry

Rockwell announces AI inspection technology

The accelerating decline of fieldbus as Ethernet takes over

ANSTO celebrates 20 years of OPAL supporting research and innovation

Engineers Australia marks International Youth Day

SPC Global expands its Aussie-made footprint across North Asia

Food fraud study in the UK estimates costs to economy

Australia and Vietnam trade talks progress

foodpro wrap-up: the event welcomed over 10,000 visitors

interpack China to partner with AIP

From compliance to circularity: three ways pharma manufacturers can rethink resource management

Tomago Aluminium smelter gets green investment

Stantec acquires Sydney-based consultancy

Researchers recover silver from end-of-life solar panels

Soft Low-E coated photovoltaic glass reduces energy demand